Filler R - Search Results

1

The contribution of Langerhans cells to cutaneous malignancy.

Lewis J, Filler R, Smith DA, Golubets K, Girardi M. Lewis J, et al. Among authors: filler r. Trends Immunol. 2010 Dec;31(12):460-6. doi: 10.1016/j.it.2010.10.001. Epub 2010 Nov 9. Trends Immunol. 2010. PMID: 21071271 Free PMC article. Review.

2

Regulation of cutaneous malignancy by gammadelta T cells.

Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Girardi M, et al. Among authors: filler r. Science. 2001 Oct 19;294(5542):605-9. doi: 10.1126/science.1063916. Epub 2001 Sep 20. Science. 2001. PMID: 11567106

3

Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation.

Girardi M, Lewis J, Glusac E, Filler RB, Geng L, Hayday AC, Tigelaar RE. Girardi M, et al. J Exp Med. 2002 Apr 1;195(7):855-67. doi: 10.1084/jem.20012000. J Exp Med. 2002. PMID: 11927630 Free PMC article.

4

Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants.

Girardi M, Sherling MA, Filler RB, Shires J, Theodoridis E, Hayday AC, Tigelaar RE. Girardi M, et al. Immunology. 2003 May;109(1):1-7. doi: 10.1046/j.1365-2567.2003.01616.x. Immunology. 2003. PMID: 12709011 Free PMC article.

5

The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer.

Girardi M, Glusac E, Filler RB, Roberts SJ, Propperova I, Lewis J, Tigelaar RE, Hayday AC. Girardi M, et al. J Exp Med. 2003 Sep 1;198(5):747-55. doi: 10.1084/jem.20021282. J Exp Med. 2003. PMID: 12953094 Free PMC article.

6

Characterizing the protective component of the alphabeta T cell response to transplantable squamous cell carcinoma.

Girardi M, Oppenheim D, Glusac EJ, Filler R, Balmain A, Tigelaar RE, Hayday AC. Girardi M, et al. Among authors: filler r. J Invest Dermatol. 2004 Mar;122(3):699-706. doi: 10.1111/j.0022-202X.2004.22342.x. J Invest Dermatol. 2004. PMID: 15086556 Free article.

7

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.

Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, Girardi M, Hayday AC. Oppenheim DE, et al. Among authors: filler r. Nat Immunol. 2005 Sep;6(9):928-37. doi: 10.1038/ni1239. Epub 2005 Aug 14. Nat Immunol. 2005. PMID: 16116470

8

Environmentally responsive and reversible regulation of epidermal barrier function by gammadelta T cells.

Girardi M, Lewis JM, Filler RB, Hayday AC, Tigelaar RE. Girardi M, et al. J Invest Dermatol. 2006 Apr;126(4):808-14. doi: 10.1038/sj.jid.5700120. J Invest Dermatol. 2006. PMID: 16439970 Free article.

9

Characterizing tumor-promoting T cells in chemically induced cutaneous carcinogenesis.

Roberts SJ, Ng BY, Filler RB, Lewis J, Glusac EJ, Hayday AC, Tigelaar RE, Girardi M. Roberts SJ, et al. Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6770-5. doi: 10.1073/pnas.0604982104. Epub 2007 Apr 5. Proc Natl Acad Sci U S A. 2007. PMID: 17412837 Free PMC article.

10

Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.

Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, Kaplan DH, Hayday AC, Girardi M. Strid J, et al. Nat Immunol. 2008 Feb;9(2):146-54. doi: 10.1038/ni1556. Epub 2008 Jan 6. Nat Immunol. 2008. PMID: 18176566 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page